Clinical Trial Update: The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis

View source ↗

Summary

The Belgian SMART trial evaluating golimumab for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Ulcerative Colitis | Status: COMPLETED